ClinicalTrials.gov
ClinicalTrials.gov Menu

A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam. (GT1110791)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00929370
Recruitment Status : Terminated (Study has now been terminated due to changes in project strategy. Current available data will be analysed and reported in a synoptic study report.)
First Posted : June 29, 2009
Last Update Posted : June 29, 2009
Sponsor:
Information provided by:
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2008
  Actual Study Completion Date : March 2009